Published in Nervenarzt on September 01, 2006
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest (1996) 2.96
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Parasuicide in Europe: the WHO/EURO multicentre study on parasuicide. I. Introduction and preliminary analysis for 1989. Acta Psychiatr Scand (1992) 2.41
Heterodimerization between light-regulated and ubiquitously expressed Arabidopsis GBF bZIP proteins. EMBO J (1992) 2.40
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry (2001) 2.27
TGA1 and G-box binding factors: two distinct classes of Arabidopsis leucine zipper proteins compete for the G-box-like element TGACGTGG. Plant Cell (1992) 2.18
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol Psychiatry (2002) 2.01
Reconstitution of transcription factor SL1: exclusive binding of TBP by SL1 or TFIID subunits. Science (1994) 1.98
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region. Plant J (1993) 1.97
Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry (1997) 1.94
DNA binding site preferences and transcriptional activation properties of the Arabidopsis transcription factor GBF1. EMBO J (1992) 1.94
Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm (1986) 1.75
Modulation of the IgH enhancer's cell type specificity through a genetic switch. Genes Dev (1991) 1.74
Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits. Science (1994) 1.70
Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med (2000) 1.52
Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study. Arch Gen Psychiatry (1990) 1.49
IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res (1992) 1.44
[Changes in the frequency of suicidal behaviour after a 2-year intervention campaign]. Nervenarzt (2007) 1.41
Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Soc Psychiatry Psychiatr Epidemiol (2000) 1.41
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection (2007) 1.39
Media recommendations on reporting suicidal behaviour and suggestions for optimisation. Acta Psychiatr Scand (2013) 1.38
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A (1999) 1.33
Attempted and completed suicide in older subjects: results from the WHO/EURO Multicentre Study of Suicidal Behaviour. Int J Geriatr Psychiatry (2001) 1.32
[The biological "activation" of Endoxan]. Naturwissenschaften (1965) 1.20
Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet (2000) 1.17
Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry (1991) 1.09
Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet (1996) 1.09
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry (1998) 1.07
Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Arch Gen Psychiatry (1975) 1.06
[Folie à deux - mental infection or individual psychosis]. Fortschr Neurol Psychiatr (2007) 1.06
Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr Bull (1999) 1.06
Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry (1997) 1.05
Relation between attempted suicide and suicide rates among young people in Europe. J Epidemiol Community Health (1998) 1.02
Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int (1998) 1.00
Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor. Biochemistry (1998) 1.00
Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology (1985) 1.00
Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry (2001) 0.98
Attempted suicide and major public holidays in Europe: findings from the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatr Scand (1999) 0.98
Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry (1995) 0.97
Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry (1991) 0.96
A promoter-associated polymorphic repeat modulates PAX-6 expression in human brain. Biochem Biophys Res Commun (1998) 0.95
Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem (1995) 0.94
Different genetic background of schizophrenia spectrum psychoses: a twin study. Am J Psychiatry (1998) 0.94
Repetition of attempted suicide among teenagers in Europe: frequency, timing and risk factors. Eur Child Adolesc Psychiatry (2001) 0.94
Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices. Eur Respir J (2003) 0.94
Towards the genetic basis of periodic catatonia: pedigree sample for genome scan I and II. Eur Arch Psychiatry Clin Neurosci (2001) 0.94
Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. Am J Med Genet (1997) 0.94
Cycloid psychoses -- from clinical concepts to biological foundations. J Neural Transm (Vienna) (2002) 0.93
Naturally occurring benzodiazepines: current status of research and clinical implications. Eur Arch Psychiatry Clin Neurosci (2000) 0.93
The different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci (2001) 0.93
The WHO-EURO Multicentre Study: risk of parasuicide and the comparability of the areas under study. Crisis (1996) 0.92
P300 asymmetries in schizophrenia revisited with reference-independent methods. Psychiatry Res (1994) 0.92
Physical illness and parasuicide: evidence from the European Parasuicide Study Interview Schedule (EPSIS/WHO-EURO). Int J Psychiatry Med (1999) 0.91
[3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm (1989) 0.90
Periodic catatonia: a schizophrenic subtype with major gene effect and anticipation. Eur Arch Psychiatry Clin Neurosci (1995) 0.90
Novel antineoplastic agents with efficacy against multidrug resistant tumor cells. Bioorg Med Chem Lett (1998) 0.90
Serotonin transporter gene polymorphism and affective disorder. Lancet (1996) 0.89
Neuroleptic malignant syndrome in Kufs' disease. J Neurol Neurosurg Psychiatry (2003) 0.89
Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm (Vienna) (1998) 0.89
Recommended care for young people (15-19 years) after suicide attempts in certain European countries. Eur Child Adolesc Psychiatry (2000) 0.88
Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet (1996) 0.88
Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrier. J Med Chem (2001) 0.87
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm (1989) 0.87
Cycloid psychoses are not part of a bipolar affective spectrum: results of a controlled family study. J Affect Disord (2004) 0.87
Rapid-onset central motor plasticity in multiple sclerosis. Neurology (2010) 0.87
Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables. Acta Psychiatr Scand (1983) 0.87
Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia. J Neural Transm Gen Sect (1994) 0.87
A repetition-prediction study of European parasuicide populations: a summary of the first report from part II of the WHO/EURO Multicentre Study on Parasuicide in co-operation with the EC concerted action on attempted suicide. Acta Psychiatr Scand (1997) 0.87
A quantitative dynamical systems approach to differential learning: self-organization principle and order parameter equations. Biol Cybern (2007) 0.86
[Clinical aspects of puerperal psychoses. Review with 3 case examples]. Nervenarzt (2002) 0.86
Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals. Acta Psychiatr Scand (1981) 0.86
Systematic screening for mutations in the 5'-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet (1996) 0.86
Cortical layer I changes in schizophrenia: a marker for impaired brain development? J Neural Transm (Vienna) (1997) 0.86
Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res (1997) 0.86
Influence of cerebral oxygenation following severe head injury on neuropsychological testing. Neurol Res (2004) 0.85
Micro-electronic monitoring of functional appliance wear. Eur J Orthod (1990) 0.85
Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study. Pharmacopsychiatria (1982) 0.85
Granule cells of the dentate gyrus with basal and recurrent dendrites in schizophrenic patients and controls. A comparative Golgi study. J Neural Transm (Vienna) (2003) 0.85
Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm Gen Sect (1994) 0.85
[Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)]. Schweiz Arch Neurol Psychiatr (1988) 0.85
The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions. Pharmacopsychiatry (2012) 0.85
Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics (2000) 0.84
The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics. Psychiatry Res (1997) 0.84
Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med (1991) 0.84
Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet (2001) 0.84
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res (1989) 0.84
[Site and depth of glaucomatous visual field defects in relation to the size of the neuroretinal edge zone of the optic disk in glaucoma without hypertension, simple glaucoma, pigmentary glaucoma. A clinical study with the Octopus perimeter 201 and the optic nerve head analyzer]. Klin Monbl Augenheilkd (1986) 0.84